Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | DGKA | P23743 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 4/20 | 0.37 |
| ▸ | PAM | P19021 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.32 |
| ▸ | NAAA | Q02083 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8463255 | 0.97 | DGKA (0.43) | TSHRDGKALMNAPAMALDH1A1 | |
| SCHEMBL16295140 | 0.97 | DGKA (0.43) | TSHRDGKALMNAPAMALDH1A1 | |
| SCHEMBL8463526 | 0.97 | DGKA (0.43) | TSHRDGKALMNAPAMALDH1A1 | |
| SCHEMBL8465959 | 0.97 | DGKA (0.43) | TSHRDGKALMNAPAMALDH1A1 | |
| SCHEMBL10739007 | 0.94 | TSHR (0.50) | TSHRDGKALMNAPAMALDH1A1 | |
| SCHEMBL19858487 | 0.91 | DGKA (0.54) | TSHRDGKALMNAPAMALDH1A1 | |
| SCHEMBL4643892 | 0.91 | GPR84 (0.41) | TSHRDGKALMNAALDH1A1MAPT | |
| SCHEMBL8467025 | 0.91 | TSHR (0.52) | TSHRLMNAALDH1A1 | |
| SCHEMBL17578973 | 0.89 | DGKA (0.57) | TSHRDGKALMNAPAMALDH1A1 | |
| SCHEMBL2701285 | 0.89 | DGKA (0.57) | TSHRDGKALMNAPAMALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130250485-A1 | MATERIALS FOR ELECTROLYTES AND METHODS FOR USE | WILDCAT DISCOVERY TECHNOLOGIES, INC. (US) | 2013-09-26 | — | — | US | claimed |
| EP-3352281-B1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY | ADEKA CORP (JP) | 2021-08-11 | — | — | EP | disclosed |
| EP-3054521-B1 | ELECTROLYTE AND LITHIUM-ION SECONDARY BATTERY | ASAHI CHEMICAL IND (JP) | 2021-06-16 | — | — | EP | disclosed |
| CN-108140887-B | Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery | 株式会社艾迪科 | 2021-03-12 | — | — | CN | disclosed |
| CN-105745779-B | Composition for addition to electrolyte solution containing silyl group-containing compound, electrolyte solution, and lithium ion secondary battery | 旭化成株式会社 | 2021-02-05 | — | — | CN | disclosed |
| US-10734684-B2 | Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery | ADEKA CORPORATION (JP) | 2020-08-04 | — | — | US | disclosed |
| EP-3038201-B1 | COMPOSITION FOR ADDITION TO ELECTROLYTE SOLUTIONS CONTAINING SILYL GROUP-CONTAINING COMPOUND, ELECTROLYTE SOLUTION FOR NONAQUEOUS ELECTRICITY STORAGE DEVICES CONTAINING SAID COMPOSITION, AND LITHIUM ION SECONDARY BATTERY CONTAINING SAID ELECTROLYTE SOLUTION | ASAHI CHEMICAL IND (JP) | 2019-10-30 | — | — | EP | disclosed |
| US-20180226683-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROPLYTE SECONDARY BATTERY | ADKEA CORPORATION (JP) | 2018-08-09 | — | — | US | disclosed |
| EP-3352281-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | Adeka Corporation (JP) | 2018-07-25 | — | — | EP | disclosed |
| US-9997805-B2 | — | — | 2018-06-12 | — | — | US | disclosed |
| EP-0792195-A1 | NON-AMINIC PHOTORESIST ADHESION PROMOTERS FOR MICROELECTRONIC APPLICATIONS | COMPLEX FLUID SYSTEMS, INC. (US) | 1997-09-03 | — | — | EP | disclosed |
| US-5622784-A | WATERPROOFING; MODIFIED SILICON DIOXIDE THIN FILM | SEIKO EPSON CORPORATION (JP) | 1997-04-22 | — | — | US | disclosed |
| EP-0564004-B1 | A highly stereoregular polypropylene | CHISSO CORP (JP) | 1996-09-25 | — | — | EP | disclosed |
| WO-1996015861-A1 | NON-AMINIC PHOTORESIST ADHESION PROMOTERS FOR MICROELECTRONIC APPLICATIONS | COMPLEX FLUID SYSTEMS, INC. (US) | 1996-05-30 | — | — | WO | disclosed |
| EP-0708793-A1 | CYCLIC ETHER POLYMERIZATION USING SILICON COMPOUND ACCELERATORS | E.I. DU PONT DE NEMOURS & COMPANY INCORPORATED (US) | 1996-05-01 | — | — | EP | disclosed |
| US-5478920-A | Cyclic ether polymerization using silicon compound accelerators | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-12-26 | — | — | US | disclosed |
| WO-1995002626-A1 | CYCLIC ETHER POLYMERIZATION USING SILICON COMPOUND ACCELERATORS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-01-26 | — | — | WO | disclosed |
| EP-0564004-A1 | A highly stereoregular polypropylene | CHISSO CORPORATION (JP) | 1993-10-06 | — | — | EP | disclosed |
| US-5077341-A | Using coordination catalyst | CHISSO CORPORATION (JP) | 1991-12-31 | — | — | US | disclosed |
| EP-0404519-A2 | A process for producing a high-stiffness polypropylene | CHISSO CORPORATION (JP) | 1990-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180226683-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROPLYTE SECONDARY BATTERY | SLC9A1, SLC8A1, KCNN1 | TSHR 3925/4885DGKA 3484/4885LMNA 2294/4885 |
| US-10734684-B2 | Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery | KCNN1, KCNN2, SLC9A1 | TSHR 3742/4885DGKA 3262/4885LMNA 2047/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.